Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Biogen Inc. Caps Off a Solid 2017, Waits on Aducanumab
Biogen Inc. Caps Off a Solid 2017, Waits on Aducanumab
Biogen Inc. Caps Off a Solid 2017, Waits on Aducanumab
Submitted by
admin
on January 29, 2018 - 11:56pm
Source:
Motley Fool
News Tags:
Biogen
aducanumab
earnings
Headline:
Biogen Inc. Caps Off a Solid 2017, Waits on Aducanumab
Do Not Allow Advertisers to Use My Personal information
